Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
AGENT FOR PREVENTING DEVELOPMENT OF REFLEX SYMPATHETIC DYSTROPHY AFTER STROKE
Document Type and Number:
WIPO Patent Application WO/2008/038644
Kind Code:
A1
Abstract:
[PROBLEMS] To provide a novel pharmaceutical agent having an excellent prophylactic effect on RSD developed after stroke. [MEANS FOR SOLVING PROBLEMS] An agent for preventing the development of RSD after stroke, comprising naturally occurring calcitonin or a calcitonin derivative as an active ingredient; a method for preventing the development of RSD after stroke, comprising administering naturally occurring calcitonin or a calcitonin derivative; and use of naturally occurring calcitonin or a calcitonin derivative for producing an agent for preventing the development of RSD after stroke.

Inventors:
MATAYOSHI SATORU (JP)
Application Number:
PCT/JP2007/068618
Publication Date:
April 03, 2008
Filing Date:
September 26, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ASAHI KASEI PHARMA CORP (JP)
MATAYOSHI SATORU (JP)
International Classes:
A61K38/23; A61K35/60; A61P21/04
Foreign References:
JPS5341677B21978-11-06
GB2092002A1982-08-11
GB2095994A1982-10-13
JPS63243033A1988-10-07
JPS63316737A1988-12-26
JPH01230530A1989-09-14
JPH02111A1990-01-05
JPH02104531A1990-04-17
JPH0499729A1992-03-31
JPH078806B21995-02-01
JP2004528900A2004-09-24
JPH0354175B21991-08-19
JPS60161924A1985-08-23
JP2000143533A2000-05-23
JPS56140924A1981-11-04
US5990166A1999-11-23
JPH11116499A1999-04-27
Other References:
MARX C. ET AL.: "Preventing Recurrence of Reflex Sympathetic Dystrophy in Patients Requiring and Operative Intervention at the Site of Dystrophy after Surgery", CLINICAL RHEUMATOLOGY, vol. 20, 2001, pages 114 - 118, XP003021922
GOBELET C. ET AL.: "The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy", PAIN, vol. 48, 1992, pages 171 - 175, XP022406983
APPELBOOM T.: "Calcitonin in Reflex sympathetic Dystrophy Syndrome and Other Painful Conditions", BONE, vol. 30, no. 5, May 2002 (2002-05-01), pages 84S - 86S, XP003005021
BUCKLE R.: "P18. The effect of calcitonin in Sudeck's atrophy", BONE AND TOOTH SOCIETY SPRING MEETING, vol. 10, no. 18, 10 April 1989 (1989-04-10), pages 480, XP003021923
YAMAGA M. ET AL.: "Nosocchu Henmahi ni Tomonau Itami Katate Shokogun", JOURNAL OF PAIN AND CLINICAL MEDICINE, vol. 4, no. 2, 2004, pages 115 - 122, XP003021924
See also references of EP 2067482A4
ISHIBASHI T.; TERAYAMA K.; KATAOKA O.: "Orthopedics - Approach to pain- 5", 1998, NANKODO CO., LTD., article "Reflex sympathetic dystrophy", pages: 183 - 197
ISHIBASHI T.; TERAYAMA K.; KATAOKA O.: "Orthopedics -Approach to pain- 5", 1998, NANKODO CO., LTD., article "Reflex sympathetic dystrophy", pages: 183 - 197
YAMAGA M. ET AL.: "Shoulder-hand syndrome", JOURNAL OF PAIN AND CLINICAL MEDICINE, vol. 4, no. 2, 2004, pages 115 - 122
CASALE R. ET AL.: "Increased sympathetic tone in the left arm of patients affected by symptomatic myocardial ischemia.", FUNCT. NEUROL., vol. 4, 1989, pages 161 - 163
DAVIET J C. ET AL.: "Clinical factors in the prognosis of complex regional pain syndrome type I after stroke: a prospective study.", AM. J. PHYS. MED. REHABIL., vol. 81, 2002, pages 34 - 39
YAMAGA M. ET AL.: "Treatment of reflex sympathetic dystrophy", NEUROLOGICAL MEDICINE, vol. 54, 2001, pages 306 - 314
ZOLLINGER PE. ET AL.: "Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomized trial.", LANCET, vol. 354, 1999, pages 2025 - 2028
KISSLING RO. ET AL.: "Prevention of recurrence of Sudeck's disease with calcitonin.", REV. CHIR. ORTHOP. REPARATRICE APPAR. MOT., vol. 77, 1991, pages 562 - 567, XP009154827
MARX C. ET AL.: "Preventing recurrence of reflex sympathetic dystrophy in patients requiring an operative intervention at the site of dystrophy after surgery.", CLIN. RHEUMATOL., vol. 20, 2001, pages 114 - 118, XP003021922, DOI: doi:10.1007/s100670170080
KONDO I. ET AL.: "Protocol to prevent shoulder-hand syndrome after stroke.", ARCH. PHYS. MED. REHABIL., vol. 82, 2001, pages 1619 - 1623, XP002665768, DOI: doi:10.1053/APMR.2001.25975
BRAUS DF. ET AL.: "The shoulder-hand syndrome after stroke: a prospective clinical trial.", ANN. NEUROL., vol. 36, 1994, pages 728 - 733
WADE S. ET AL.: "A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes.", PAIN, USA, vol. 73, 1997, pages 123 - 139, XP002119434, DOI: doi:10.1016/S0304-3959(97)00049-3
"Antonio Quatraro: Calcitonin in painful diabetic neuropathy", LANCET, vol. 339, 1992, pages 746 - 747
RIOU C. ET AL.: "Can algodystrophy be prevented by thyrocalcitonin?, Rev. Chir. Orthop", REPARATRICE APPAR. MOT., vol. 77, 1991, pages 208 - 210
HELV. CHIM. ACTA, vol. 52, no. 7, 1969, pages 1789 - 95
HIRAI S., JAPANESE JOURNAL OF CLINICAL MEDICINE, 1993
"Strokology in the age of CT and MRI", vol. 7-19, NIPPON RINSHO-SHA CO., LTD.
VELDMAN ET AL.: "Signs and Symptoms of reflex sympathetic dystrophy: prospective study of 829 patients", LANCET, vol. 342, 1993, pages 1012 - 1016
JANI W.: "Reflex sympathetic dystrophy", 1992, VCH, article "Is the reflex sympathetic dystrophy a neurological disease?", pages: 9 - 26
TAKAHASHI A.: "Conditions and diagnosis of reflex sympathetic dystrophy", NEUROLOGICAL MEDICINE, vol. 54, 2001, pages 292 - 296
YAMAGA M. ET AL.: "Shoulder-hand syndrome", JOURNAL OF PAIN AND CLINICAL MEDICINE, vol. 4, 2004, pages 115 - 122
ACADEMY OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, pages 57 - 58
ANN. N.Y. ACAD. SCI., vol. 507, 1988, pages 32
ENDOCRINOL. JPN., vol. 23, 1976, pages 493
HORMONE RES., vol. 16, 1982, pages 249
PHARMAZIE, vol. 61, no. 2, 2006, pages 106 - 111
CALCIF. TISSUE INT., vol. 46, 1990, pages 5 - 8
BIOL. PHARM. BULL., vol. 18, no. 6, 1995, pages 900
J BONE MINER RES, vol. 17, 2002, pages 1478 - 1485
CURRENT MEDIAL CARE, vol. 20, no. 12, 1978, pages 2217
Attorney, Agent or Firm:
KAWAGUCHI, Yoshio et al. (Jochi Kioizaka Bldg.7-1 Kioi-ch, Chiyoda-ku Tokyo 94, JP)
Download PDF: